Oesophageal Carcinoma
7
0
1
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
28.6%
2 terminated out of 7 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
MRinRT: Swansea University and SWWCC Collaboration Study.
Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
The Bacterial Composition of the Stomach in Reflux Disease
A Study of APR-246 in Oesophageal Cancer
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus